Skip to main content

[vc_row][vc_column width="1/4"][vc_single_image image="27042" img_size="large" css=""][/vc_column][vc_column width="3/4"][vc_column_text css=""]In what could be a major breakthrough, scientists at the Korea Advanced Institute of Science and Technology (KAIST) in South Korea claim to have identified the cellular origin of glioblastoma, a fast-growing type of central nervous system tumor that...

[vc_row][vc_column][vc_column_text css=""] [caption id="attachment_26746" align="aligncenter" width="1050"] Melinda Bachini (second to left) with her husband and 6 children.[/caption] On December 1, 2009 at age 41, I was diagnosed with Intrahepatic Cholangiocarcinoma, aka Bile Duct Cancer—a very rare, aggressive and difficult to treat type of cancer. Just 20 days...

[vc_row][vc_column][vc_single_image image="25256" img_size="full" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]While it may not be an extremely common cancer, multiple myeloma, awareness of which is highlighted throughout the month of March, remains a severe, life-threatening disease. Multiple myeloma is a cancer affecting plasma cells within the bone marrow. With the cancer...

[vc_row][vc_column][vc_single_image image="24494" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Approved in June 2017 by the U.S. Food and Drug Administration and launched commercially in-country in October 2018, 5-Aminolevulinic Acid (also known as 5-ALA, and composed of aminolevulinic acid hydrochloride) is an optical imaging agent for use in patients with...